Trials / Recruiting
RecruitingNCT06533163
Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- BioTex, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The clinical investigation is a non-randomized, multicenter, open-label, prospective, exposure-time escalation clinical investigation. The clinical investigation is designed to assess the clinical safety and performance of the Oncomagnetic Device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Oncomagnetic device | OncoMAGNETX has developed a portable wearable noninvasive magnetic device (Oncomagnetic device) for the treatment of GBM. |
Timeline
- Start date
- 2025-02-17
- Primary completion
- 2027-11-01
- Completion
- 2027-11-01
- First posted
- 2024-08-01
- Last updated
- 2025-07-14
Locations
6 sites across 1 country: Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06533163. Inclusion in this directory is not an endorsement.